Dabur India Limited has reported consolidated financial results for the period ended March 31, 2024.
BENGALURU, Nov 15 (Reuters) - Dabur India (DABU.NS) said on Wednesday a U.S. court had dismissed two of its three subsidiaries as defendants in a lawsuit tying the use of hair relaxer products to ovarian and uterine cancers as well as other health issues.
Dabur India`s units face lawsuits in US, Canada alleging products caused cancer
Dabur India Limited has reported total income of Rs. 3144.01 crores during the period ended December 31, 2022 as compared to Rs. 3109.77 crores during the period ended September 30, 2022. It reported total income of Rs.3038.49 crores during the period ended December 31, 2021.